Rapid growth in commercial & government rebates has resulted in GTN reductions above 50% of gross sales for traditional brands. Gross-to-net sales continue to be impacted by significant volatility, high risk exposure, and material true-up adjustments.

By attending this virtual course, you'll learn about:

• Sales forecasting and GTN sensitivity analysis
• PBM revenue sources and impact of leveraging aggregated demand
• Impact of payer formulary exclusions, prior authorization and step edits
• Implications of escalating patient out-of-pocket costs on prescription abandonment
• Forecasting payer mix and rebate percentages to establish accrual rates
• True-up adjustments
• Key factors impacting rebate rates
• Chargebacks
• Copay assistance programs, accumulators & maximizers 
• Wholesaler fees
• Accounting for product returns
• GTN pipeline and demand liability
• Third-party data sources